Regulatory Challenges
Pharmaceutical companies operate within a constantly evolving regulatory landscape that presents significant challenges. This segment will focus on key regulatory hurdles in the drug approval process, including global harmonization efforts. It will also explore strategies for navigating FDA and EMA requirements, regulatory flexibility during public health emergencies, and the impact of regulations on pharmaceutical manufacturing.
Sub-Sessions:
- Regulatory Hurdles in Drug Approval
- Global Regulatory Harmonisation
- Navigating FDA and EMA Approval Processes
- Regulatory Flexibility in Emergencies
- Regulatory Impact on Manufacturing